CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Parthenolide 100mg  | ≥98%

CSNpharm

Parthenolide is a sesquiterpene lactone from the plant feverfew (T. parthenium) with multiple biological functions. Parthenolide inhibits the growth of the promastigote form of L. amazonensis with IC50 of 3.6 μg/mL, induces apoptosis in cancer cells and blocks inflammation by inhibiting signaling through NF-κB.

More Information Supplier Page

Parthenolide 250mg  | ≥98%

CSNpharm

Parthenolide is a sesquiterpene lactone from the plant feverfew (T. parthenium) with multiple biological functions. Parthenolide inhibits the growth of the promastigote form of L. amazonensis with IC50 of 3.6 μg/mL, induces apoptosis in cancer cells and blocks inflammation by inhibiting signaling through NF-κB.

More Information Supplier Page

Parthenolide 50mg  | ≥98%

CSNpharm

Parthenolide is a sesquiterpene lactone from the plant feverfew (T. parthenium) with multiple biological functions. Parthenolide inhibits the growth of the promastigote form of L. amazonensis with IC50 of 3.6 μg/mL, induces apoptosis in cancer cells and blocks inflammation by inhibiting signaling through NF-κB.

More Information Supplier Page

Pasiniazid 100mg  | ≥98%

CSNpharm

Pasiniazid is a composition of isoniazid and 4-aminosalicylic acid, that has mutual effects coupling isoniazid and 4-aminosalicylic acid for use in tuberculosis patients.

More Information Supplier Page

Pasiniazid 1g  | ≥98%

CSNpharm

Pasiniazid is a composition of isoniazid and 4-aminosalicylic acid, that has mutual effects coupling isoniazid and 4-aminosalicylic acid for use in tuberculosis patients.

More Information Supplier Page

PCI-29732 25mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI-29732 10mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI-29732 5mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI-29732 100mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI-29732 1mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PCI-29732 50mg  | ≥98%

CSNpharm

PCI 29732 is a selective and irreversible Btk inhibitor with IC50 of 8.2 nM in a FRET based biochemical enzymology assay.

More Information Supplier Page

PD 128907 HCl 1g  | ≥98%

CSNpharm

PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.

More Information Supplier Page

PD 128907 HCl 250mg  | ≥98%

CSNpharm

PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.

More Information Supplier Page

PD 128907 HCl 100mg  | ≥98%

CSNpharm

PD 128907 HCl is a potent and selective dopamine D3 receptor agonist, with EC50 of 0.64 nM, exhibits 53-fold selectivity over dopamine D2 receptor.

More Information Supplier Page

PD 168077 Maleate 50mg  | ≥98%

CSNpharm

PD 168077 maleate is an agonist of D4 dopamine receptor with Ki of 8.7 nM. It can induce synaptic translocation of CaMK II to postsynaptic sites in cultured prefrontal cortical neurons.

More Information Supplier Page

PD 168077 Maleate 100mg  | ≥98%

CSNpharm

PD 168077 maleate is an agonist of D4 dopamine receptor with Ki of 8.7 nM. It can induce synaptic translocation of CaMK II to postsynaptic sites in cultured prefrontal cortical neurons.

More Information Supplier Page

PD 168077 Maleate 25mg  | ≥98%

CSNpharm

PD 168077 maleate is an agonist of D4 dopamine receptor with Ki of 8.7 nM. It can induce synaptic translocation of CaMK II to postsynaptic sites in cultured prefrontal cortical neurons.

More Information Supplier Page

PD 168077 Maleate 5mg  | ≥98%

CSNpharm

PD 168077 maleate is an agonist of D4 dopamine receptor with Ki of 8.7 nM. It can induce synaptic translocation of CaMK II to postsynaptic sites in cultured prefrontal cortical neurons.

More Information Supplier Page

PD 168077 Maleate 10mg  | ≥98%

CSNpharm

PD 168077 maleate is an agonist of D4 dopamine receptor with Ki of 8.7 nM. It can induce synaptic translocation of CaMK II to postsynaptic sites in cultured prefrontal cortical neurons.

More Information Supplier Page

PD153035 50mg  | ≥99%

CSNpharm

PD153035 is EGFR inhibitor with Ki and IC50 of 5.2 pM and 29 pM and could rapidly suppress autophosphorylation of EGFR.

More Information Supplier Page